Advertisement

Fatal Agranulocytosis and Fournier’s Gangrene due to the Use of Metamizole

  • Nagehan Aslan
  • Dincer Yildizdas
  • Ozden Ozgur Horoz
  • Onder Ozden
Scientific Letter
  • 39 Downloads

Notes

Compliance with Ethical Standards

Conflict of Interest

None.

References

  1. 1.
    Blake FG, Winternitz MC, Geiger AJ, Leonard JC, Opper L. Yale case studies: agranulocyticanjina. Yale J Biol Med. 1935;7:465–71.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Salama A, Schtz B, Kiefel V, et al. Immune-mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies. Br J Haematol. 1989;72:127–32.CrossRefGoogle Scholar
  3. 3.
    Stammschulte T, Ludwig WD, Muhlbauer B, et al. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012. Eur J Clin Pharmacol. 2015;71:1129–38.CrossRefGoogle Scholar
  4. 4.
    Safioleas MC, Stamatakos MC, Diab AI, Safioleas PM. The use of oxygen in Fournier’s gangrene. Saudi Med J. 2006;27:1748–50.PubMedGoogle Scholar
  5. 5.
    Winkler A, Kiets S, Bahlmann H, et al. GM-CSF as successful salvage therapy of metamizole (dypirone) induced agranulocytosis with Fournier’s gangrene and severe septic shock in an adolescent. Clin Case Rep. 2016;4:816–9.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2018

Authors and Affiliations

  1. 1.Department of Pediatric Intensive Care UnitCukurova University Faculty of MedicineAdanaTurkey
  2. 2.Department of Pediatric SurgeryCukurova University Faculty of MedicineAdanaTurkey

Personalised recommendations